Contacts Investors Media Traci McCarty Andrew Villani BioMarin Pharmaceutical Inc BioMarin Pharmaceutical Inc 415 4557558 628 2697393 SOURCE BioMarin Pharmaceutical Inc 102023 805 PM US Food and Drug Administration Approves BioMarins VOXZOGO vosoritide for Children Under 5 Years with Achondroplasia  Oct 20  httpsinvestorsbiomarincom20231020USFoodandDrugAdministrationApprovesBioMarinsVOXZOGORvosoritideforChildrenUnder5Yearswith 1111Our Treatments Our Company Investors  MediaOur Products Our Pipeline Leadership Team Board of Directors Diversity Equity  Inclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request Funding  SupportConnect Careers LinkedIn Facebook Instagram YouTube Privacy Policy Terms of Use Site Map Supplier Information Slavery Act Statement Glossary Contact Us  2023 BioMarin